Recurrences and bleeding during extended treatment of patients with venous thromboembolism: results of the international, prospective, observational WHITE study.

Gualtiero Palareti,Victor Barinov,Tomasz Urbanek,Michela Cini,Young-Jun Li,Kamel Bouslama,Jiří Matuška,Armando Mansilha,Juraj Madaric,German Y Sokurenko,Giuseppe M Andreozzi

International angiology : a journal of the International Union of Angiology（2023）

引用 1|浏览13

暂无评分

摘要

DOACs were the most used drugs for extended treatments. Overall, the rate of primary events during FU was low. The investigators identified patients at low risk of recurrence and high bleeding risk. Sulodexide use for secondary prevention deserves further studies.

查看译文

关键词

Venous thromboembolism, Therapeutics, Factor Xa inhibitors, Platelet aggregation inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要